Haleos Labs Limited (HALEOSLABS)
FAST GROWERScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,415 |
| Market Cap | ₹381.02 Cr |
| P/E Ratio | 19.19 |
| ROCE | 11.78% |
| ROE | 9.69% |
| Dividend Yield | 0.12% |
| Profit Growth | 21.02% |
| Debt/Equity | 0.31 |
| Sales Growth | 12.03% |
| Promoter Holding | 71.8% |
| 52-Week Range | ₹1,091.1 — ₹1,778.35 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹630.73 |
Haleos Labs Limited trades with a P/E ratio of 19.19, ROCE of 11.78%, ROE of 9.69%, profit growth of 21.02%, debt-to-equity of 0.31.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer